Book Cover
Home  |   Healthcare   |  Pediatric Drugs and Vaccines Market

Pediatric Drugs and Vaccines Market Size, Share, Growth, and Industry Analysis, By Type (Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Mumps, Others), By Application (Newborn, Infant, Child), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Detailed TOC of Global Pediatric Drugs and Vaccines Market Trends Analysis Report 2026, Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Pediatric Drugs and Vaccines Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Pediatric Drugs and Vaccines Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Pediatric Drugs and Vaccines Business Mode and Production Process
2.3.1 Pediatric Drugs and Vaccines Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Pediatric Drugs and Vaccines Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Pediatric Drugs and Vaccines
2.4.2 Raw Material Cost of Pediatric Drugs and Vaccines
2.4.3 Labor Cost of Pediatric Drugs and Vaccines
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Pediatric Drugs and Vaccines Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Pediatric Drugs and Vaccines Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Pediatric Drugs and Vaccines Price by Manufacturer (2021-2026)
4.4 Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Pediatric Drugs and Vaccines, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Pediatric Drugs and Vaccines, Product Offered and Application
4.7 Pediatric Drugs and Vaccines Market Competitive Situation and Trends
4.7.1 Pediatric Drugs and Vaccines Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Pediatric Drugs and Vaccines Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Pediatric Drugs and Vaccines Market Historical Development by Geographic Region (2021-2026)
5.1 Global Pediatric Drugs and Vaccines Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Pediatric Drugs and Vaccines Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Pediatric Drugs and Vaccines Market Status by Country (2021-2026)
5.3.1 North America Pediatric Drugs and Vaccines Sales Volume by Country (2021-2026)
5.3.2 North America Pediatric Drugs and Vaccines Revenue by Country (2021-2026)
5.3.3 United States Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Pediatric Drugs and Vaccines Market Status by Country (2021-2026)
5.4.1 Europe Pediatric Drugs and Vaccines Sales Volume by Country (2021-2026)
5.4.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2021-2026)
5.4.3 Germany Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Pediatric Drugs and Vaccines Market Status by Country (2021-2026)
5.5.1 Asia Pacific Pediatric Drugs and Vaccines Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Country (2021-2026)
5.5.3 China Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Pediatric Drugs and Vaccines Market Status by Country (2021-2026)
5.6.1 Latin America Pediatric Drugs and Vaccines Sales Volume by Country (2021-2026)
5.6.2 Latin America Pediatric Drugs and Vaccines Revenue by Country (2021-2026)
5.6.3 Mexico Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Pediatric Drugs and Vaccines Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Pediatric Drugs and Vaccines Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2021-2026)
5.7.3 GCC Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Pediatric Drugs and Vaccines Sales Volume, Revenue and Growth (2021-2026)

6 Global Pediatric Drugs and Vaccines Market Historical Development by Product Type (2021-2026)
6.1 Pediatric Drugs and Vaccines Definition by Type
6.2 Global Pediatric Drugs and Vaccines Historical Sales Volume by Product Type (2021-2026)
6.3 Global Pediatric Drugs and Vaccines Historical Revenue by Product Type (2021-2026)
6.4 Global Pediatric Drugs and Vaccines Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Diphtheria (2021-2026)
6.5.2 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Influenza (2021-2026)
6.5.3 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Hepatitis (2021-2026)
6.5.4 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Pneumococcal Diseases (2021-2026)
6.5.5 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Meningococcal Diseases (2021-2026)
6.5.6 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Mumps (2021-2026)
6.5.7 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

7 Global Pediatric Drugs and Vaccines Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Pediatric Drugs and Vaccines Historical Sales Volume by End User (2021-2026)
7.3 Global Pediatric Drugs and Vaccines Historical Revenue by End User (2021-2026)
7.4 Global Pediatric Drugs and Vaccines Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Newborn (2021-2026)
7.5.2 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Infant (2021-2026)
7.5.3 Global Pediatric Drugs and Vaccines Historical Sales Volume, Revenue and Growth Rate of Child (2021-2026)

8 Leading Companies Profiles
8.1 Novartis AG
8.1.1 Novartis AG Corporation Information
8.1.2 Novartis AG - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.1.3 Novartis AG Performance Analysis (2021-2026)
8.1.4 Novartis AG Business and Markets Served
8.1.5 Novartis AG Recent Developments
8.2 Takeda
8.2.1 Takeda Corporation Information
8.2.2 Takeda - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.2.3 Takeda Performance Analysis (2021-2026)
8.2.4 Takeda Business and Markets Served
8.2.5 Takeda Recent Developments
8.3 Merck & Co., Inc.
8.3.1 Merck & Co., Inc. Corporation Information
8.3.2 Merck & Co., Inc. - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.3.3 Merck & Co., Inc. Performance Analysis (2021-2026)
8.3.4 Merck & Co., Inc. Business and Markets Served
8.3.5 Merck & Co., Inc. Recent Developments
8.4 Genentech, Inc.
8.4.1 Genentech, Inc. Corporation Information
8.4.2 Genentech, Inc. - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.4.3 Genentech, Inc. Performance Analysis (2021-2026)
8.4.4 Genentech, Inc. Business and Markets Served
8.4.5 Genentech, Inc. Recent Developments
8.5 Bristol-Myers Squibb Company
8.5.1 Bristol-Myers Squibb Company Corporation Information
8.5.2 Bristol-Myers Squibb Company - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.5.3 Bristol-Myers Squibb Company Performance Analysis (2021-2026)
8.5.4 Bristol-Myers Squibb Company Business and Markets Served
8.5.5 Bristol-Myers Squibb Company Recent Developments
8.6 Janssen Biologics B.V.
8.6.1 Janssen Biologics B.V. Corporation Information
8.6.2 Janssen Biologics B.V. - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.6.3 Janssen Biologics B.V. Performance Analysis (2021-2026)
8.6.4 Janssen Biologics B.V. Business and Markets Served
8.6.5 Janssen Biologics B.V. Recent Developments
8.7 Shionogi Inc.
8.7.1 Shionogi Inc. Corporation Information
8.7.2 Shionogi Inc. - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.7.3 Shionogi Inc. Performance Analysis (2021-2026)
8.7.4 Shionogi Inc. Business and Markets Served
8.7.5 Shionogi Inc. Recent Developments
8.8 F. Hoffmann-La Roche Ltd
8.8.1 F. Hoffmann-La Roche Ltd Corporation Information
8.8.2 F. Hoffmann-La Roche Ltd - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.8.3 F. Hoffmann-La Roche Ltd Performance Analysis (2021-2026)
8.8.4 F. Hoffmann-La Roche Ltd Business and Markets Served
8.8.5 F. Hoffmann-La Roche Ltd Recent Developments
8.9 Novo Nordisk A/S
8.9.1 Novo Nordisk A/S Corporation Information
8.9.2 Novo Nordisk A/S - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.9.3 Novo Nordisk A/S Performance Analysis (2021-2026)
8.9.4 Novo Nordisk A/S Business and Markets Served
8.9.5 Novo Nordisk A/S Recent Developments
8.10 Sanofi S.A
8.10.1 Sanofi S.A Corporation Information
8.10.2 Sanofi S.A - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.10.3 Sanofi S.A Performance Analysis (2021-2026)
8.10.4 Sanofi S.A Business and Markets Served
8.10.5 Sanofi S.A Recent Developments
8.11 Abbott Laboratories
8.11.1 Abbott Laboratories Corporation Information
8.11.2 Abbott Laboratories - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.11.3 Abbott Laboratories Performance Analysis (2021-2026)
8.11.4 Abbott Laboratories Business and Markets Served
8.11.5 Abbott Laboratories Recent Developments
8.12 Amgen, Inc.
8.12.1 Amgen, Inc. Corporation Information
8.12.2 Amgen, Inc. - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.12.3 Amgen, Inc. Performance Analysis (2021-2026)
8.12.4 Amgen, Inc. Business and Markets Served
8.12.5 Amgen, Inc. Recent Developments
8.13 GlaxoSmithKline plc.
8.13.1 GlaxoSmithKline plc. Corporation Information
8.13.2 GlaxoSmithKline plc. - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.13.3 GlaxoSmithKline plc. Performance Analysis (2021-2026)
8.13.4 GlaxoSmithKline plc. Business and Markets Served
8.13.5 GlaxoSmithKline plc. Recent Developments
8.14 Actelion Pharmaceuticals
8.14.1 Actelion Pharmaceuticals Corporation Information
8.14.2 Actelion Pharmaceuticals - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.14.3 Actelion Pharmaceuticals Performance Analysis (2021-2026)
8.14.4 Actelion Pharmaceuticals Business and Markets Served
8.14.5 Actelion Pharmaceuticals Recent Developments
8.15 Allergan, Inc.
8.15.1 Allergan, Inc. Corporation Information
8.15.2 Allergan, Inc. - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.15.3 Allergan, Inc. Performance Analysis (2021-2026)
8.15.4 Allergan, Inc. Business and Markets Served
8.15.5 Allergan, Inc. Recent Developments
8.16 Boehringer Ingelheim GmbH
8.16.1 Boehringer Ingelheim GmbH Corporation Information
8.16.2 Boehringer Ingelheim GmbH - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.16.3 Boehringer Ingelheim GmbH Performance Analysis (2021-2026)
8.16.4 Boehringer Ingelheim GmbH Business and Markets Served
8.16.5 Boehringer Ingelheim GmbH Recent Developments
8.17 Eli Lilly and Company
8.17.1 Eli Lilly and Company Corporation Information
8.17.2 Eli Lilly and Company - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.17.3 Eli Lilly and Company Performance Analysis (2021-2026)
8.17.4 Eli Lilly and Company Business and Markets Served
8.17.5 Eli Lilly and Company Recent Developments
8.18 AstraZeneca Plc.
8.18.1 AstraZeneca Plc. Corporation Information
8.18.2 AstraZeneca Plc. - Pediatric Drugs and Vaccines Product Portfolio and Specification
8.18.3 AstraZeneca Plc. Performance Analysis (2021-2026)
8.18.4 AstraZeneca Plc. Business and Markets Served
8.18.5 AstraZeneca Plc. Recent Developments

9 Global Pediatric Drugs and Vaccines Market Forecast by Product Type and End User (2026-2035)
9.1 Global Pediatric Drugs and Vaccines Market Forecast by Product Type (2026-2035)
9.1.1 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Diphtheria (2026-2035)
9.1.2 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Influenza (2026-2035)
9.1.3 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Hepatitis (2026-2035)
9.1.4 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Pneumococcal Diseases (2026-2035)
9.1.5 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Meningococcal Diseases (2026-2035)
9.1.6 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Mumps (2026-2035)
9.1.7 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2035)
9.2 Global Pediatric Drugs and Vaccines Market Forecast by End User (2026-2035)
9.2.1 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Newborn (2026-2035)
9.2.2 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Infant (2026-2035)
9.2.3 Global Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth Rate of Child (2026-2035)

10 Global Pediatric Drugs and Vaccines Market Forecast by Geographic Region (2026-2035)
10.1 Global Pediatric Drugs and Vaccines Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Pediatric Drugs and Vaccines Sales Volume, Revenue Forecast and Growth (2026-2035)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
 
Captcha refresh

Trusted & Certified

Our Clients